Since the genomic alterations close to the root node are genes frequently mutated in cancers, such as BRAF, which should be of better clinical potential, we then narrowed down those genomic alterations by optimally selecting the alterations associated with the first node of the tree. The gene discussed is BRAF; the disease is cancer.